Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and Differences

ABSTRACT The chimpanzee is the only animal model for investigating the pathogenesis of viral hepatitis types A through E in humans. Studies of the host response, including microarray analyses, have relied on the close relationship between these two primate species: chimpanzee samples are commonly tested with human-based reagents. In this study, the host responses to two dissimilar viruses, hepatitis E virus (HEV) and hepatitis C virus (HCV), were compared in multiple experimentally infected chimpanzees. Affymetrix U133 + 2.0 human microarray chips were used to assess the entire transcriptome in serial liver biopsies obtained over the course of the infections. Respecting the limitations of microarray probes designed for human target transcripts to effectively assay chimpanzee transcripts, we conducted probe-level analysis of the microarray data in conjunction with a custom mapping of the probe sequences to the most recent human and chimpanzee genome sequences. Time points for statistical comparison were chosen based on independently measured viremia levels. Regardless of the viral infection, the alignment of differentially expressed genes to the human genome sequence resulted in a larger number of genes being identified when compared with alignment to the chimpanzee genome sequence. This probably reflects the lesser refinement of gene annotation for chimpanzees. In general, the two viruses demonstrated very distinct temporal changes in host response genes, although both RNA viruses induced genes that were involved in many of the same biological systems, including interferon-induced genes. The host response to HCV infection was more robust in the magnitude and number of differentially expressed genes compared to HEV infection.

[1]  K. Sugano,et al.  Hepatitis E Virus (HEV) Strains in Serum Samples Can Replicate Efficiently in Cultured Cells Despite the Coexistence of HEV Antibodies: Characterization of HEV Virions in Blood Circulation , 2010, Journal of Clinical Microbiology.

[2]  G. Dore,et al.  HCV reinfection studies and the door to vaccine development. , 2009, Journal of hepatology.

[3]  Junhee Seok,et al.  Using high-density exon arrays to profile gene expression in closely related species , 2009, Nucleic acids research.

[4]  R. Fisher,et al.  Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma , 2009, Molecular medicine.

[5]  H. Blum,et al.  Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine , 2008, Biological chemistry.

[6]  I. Mushahwar Hepatitis E virus: Molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention , 2008, Journal of medical virology.

[7]  R. Purcell,et al.  Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays , 2008, Journal of medical virology.

[8]  Baohua Gu,et al.  Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus , 2007, Journal of Virology.

[9]  M. Torbenson,et al.  Histology of Symptomatic Acute Hepatitis C Infection in Immunocompetent Adults , 2007, The American journal of surgical pathology.

[10]  U. Certa,et al.  Antiproliferative Activity of the Human IFN-α-Inducible Protein IFI44 , 2007 .

[11]  J. Mathew,et al.  The histology of acute autochthonous hepatitis E virus infection , 2007, Histopathology.

[12]  R. Aggarwal,et al.  Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. , 2007, Viral immunology.

[13]  S. Emerson,et al.  In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells , 2007, Journal of Virology.

[14]  P. Brousset,et al.  Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France , 2007, Virchows Archiv.

[15]  C. Hohenadl,et al.  Unique features of different members of the human guanylate-binding protein family. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[16]  M. D'Esposito,et al.  Wide gene expression profiling of ischemia‐reperfusion injury in human liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  W. Merrick,et al.  Distinct Induction Patterns and Functions of Two Closely Related Interferon-inducible Human Genes, ISG54 and ISG56* , 2006, Journal of Biological Chemistry.

[18]  Rafael A. Irizarry,et al.  Comparison of Affymetrix GeneChip expression measures , 2006, Bioinform..

[19]  Stephen L. Chen,et al.  The Natural History of Hepatitis C Virus (HCV) Infection , 2006, International journal of medical sciences.

[20]  Ralf Bartenschlager,et al.  Quantitative Analysis of the Hepatitis C Virus Replication Complex , 2005, Journal of Virology.

[21]  E. Borden,et al.  Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. , 2005, Biochemical and biophysical research communications.

[22]  Xiaojing Ma,et al.  Interferon Regulatory Factor 1 Is an Essential and Direct Transcriptional Activator for Interferon γ-induced RANTES/CCl5 Expression in Macrophages* , 2005, Journal of Biological Chemistry.

[23]  Isaac S. Kohane,et al.  Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements , 2005, BMC Bioinformatics.

[24]  S. Lemon,et al.  Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees , 2004, Journal of Virology.

[25]  F. Ramalho Hepatitis C virus infection and liver steatosis. , 2003, Antiviral research.

[26]  S. Emerson,et al.  Hepatitis E Virus (HEV) Capsid Antigens Derived from Viruses of Human and Swine Origin Are Equally Efficient for Detecting Anti-HEV by Enzyme Immunoassay , 2002, Journal of Clinical Microbiology.

[27]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. André,et al.  Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles , 2002, Journal of Virology.

[29]  R. Lanford,et al.  DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.

[30]  P. Venge,et al.  Lipocalins as biochemical markers of disease. , 2000, Biochimica et biophysica acta.

[31]  S. Emerson,et al.  Identification by Phage Display and Characterization of Two Neutralizing Chimpanzee Monoclonal Antibodies to the Hepatitis E Virus Capsid Protein , 2000, Journal of Virology.

[32]  S. Jameel,et al.  Molecular biology and pathogenesis of hepatitis E virus , 1999, Expert Reviews in Molecular Medicine.

[33]  A. Heath,et al.  Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA , 1999, Vox Sanguinis.

[34]  J. Carton,et al.  Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. , 1999, Virology.

[35]  Desai Hg,et al.  Subacute hepatic failure: diagnosis of exclusion? , 1998 .

[36]  D. Vlahov,et al.  Seroreactivity to hepatitis E virus in areas where the disease is not endemic , 1997, Journal of clinical microbiology.

[37]  J. Fricker Hepatitis E vaccine. , 1996, Molecular medicine today.

[38]  A. Haas,et al.  Immunoregulatory properties of ISG15, an interferon-induced cytokine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[40]  S. Emerson,et al.  ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. , 1993, The Journal of infectious diseases.

[41]  R. Purcell,et al.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Purcell,et al.  Non-A, non-B hepatitis in chimpanzees and marmosets. , 1981, The Journal of infectious diseases.

[43]  Dong-liang Yang 杨东亮,et al.  Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[44]  U. Certa,et al.  Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[45]  H. Desai,et al.  Subacute hepatic failure: diagnosis of exclusion? , 1998, Journal of Clinical Gastroenterology.

[46]  R. Esteban,et al.  Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.

[47]  R H Purcell,et al.  Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. , 1992, Proceedings of the National Academy of Sciences of the United States of America.